Benjamin J W Chow1, Gary Small1, Yeung Yam1, Li Chen1, Ruth McPherson1, Stephan Achenbach1, Mouaz Al-Mallah1, Daniel S Berman1, Matthew J Budoff1, Filippo Cademartiri1, Tracy Q Callister1, Hyuk-Jae Chang1, Victor Y Cheng1, Kavitha Chinnaiyan1, Ricardo Cury1, Augustin Delago1, Allison Dunning1, Gundrun Feuchtner1, Martin Hadamitzky1, Jörg Hausleiter1, Ronald P Karlsberg1, Philipp A Kaufmann1, Yong-Jin Kim1, Jonathon Leipsic1, Troy LaBounty1, Fay Lin1, Erica Maffei1, Gilbert L Raff1, Leslee J Shaw1, Todd C Villines1, James K Min2. 1. From the Department of Medicine (Cardiology), University of Ottawa Heart Institute, Ottawa, Ontario, Canada (B.J.W.C., G.S., Y.Y., L.C., R.M.); Department of Medicine, University of Erlangen, Erlangen, Germany (S.A.); Department of Medicine, Henry Ford Hospital, Wayne State University, Detroit, MI (M.A.-M.); Department of Imaging, Cedars Sinai Medical Center, Los Angeles, CA (D.S.B., V.Y.C., T.L.); Department of Medicine, Harbor University of California, Los Angeles Medical Center (M.J.B.); Department of Radiology, Giovanni XXIII Hospital, Monastier di Treviso, Italy (F.C., E.M.); Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands (F.C., E.M.); Tennessee Heart and Vascular Institute, Hendersonville (T.Q.C.); Division of Cardiology, Severance Cardiovascular Hospital, Seoul, Korea (H.-J.C.); William Beaumont Hospital, Royal Oaks, MI (K.C.); Baptist Cardiac and Vascular Institute, Miami, FL (R.C.); Capitol Cardiology Associates, Albany, NY (A.D.); Department of Public Health (A.D.), Medicine and Radiology (F.L.), and Department of Radiology (J.K.M.), New York Presbyterian Hospital and the Weill Cornell Medical College; Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria (G.F.); Division of Cardiology, Technische Universität München, Munich, Germany (M.H., J.H.); Cardiovascular Medical Group, Los Angeles, CA (R.P.K.); Cardiac Imaging, University Hospital, Zurich, Switzerland (P.A.K.); Seoul National University Hospital, Seoul, South Korea (Y.-J.K.); Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.L.); Department of Cardiology, William Beaumont Hospital, Royal Oaks, MI (G.L.R.); Department of Medicine, Emory University School of Medicine, Atlanta, GA (L.J.S.); and Department of Medicine, Walter Reed Medical Center, Washington, DC (T.C.V.). 2. From the Department of Medicine (Cardiology), University of Ottawa Heart Institute, Ottawa, Ontario, Canada (B.J.W.C., G.S., Y.Y., L.C., R.M.); Department of Medicine, University of Erlangen, Erlangen, Germany (S.A.); Department of Medicine, Henry Ford Hospital, Wayne State University, Detroit, MI (M.A.-M.); Department of Imaging, Cedars Sinai Medical Center, Los Angeles, CA (D.S.B., V.Y.C., T.L.); Department of Medicine, Harbor University of California, Los Angeles Medical Center (M.J.B.); Department of Radiology, Giovanni XXIII Hospital, Monastier di Treviso, Italy (F.C., E.M.); Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands (F.C., E.M.); Tennessee Heart and Vascular Institute, Hendersonville (T.Q.C.); Division of Cardiology, Severance Cardiovascular Hospital, Seoul, Korea (H.-J.C.); William Beaumont Hospital, Royal Oaks, MI (K.C.); Baptist Cardiac and Vascular Institute, Miami, FL (R.C.); Capitol Cardiology Associates, Albany, NY (A.D.); Department of Public Health (A.D.), Medicine and Radiology (F.L.), and Department of Radiology (J.K.M.), New York Presbyterian Hospital and the Weill Cornell Medical College; Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria (G.F.); Division of Cardiology, Technische Universität München, Munich, Germany (M.H., J.H.); Cardiovascular Medical Group, Los Angeles, CA (R.P.K.); Cardiac Imaging, University Hospital, Zurich, Switzerland (P.A.K.); Seoul National University Hospital, Seoul, South Korea (Y.-J.K.); Department of Medicine and Radiology, University of British Columbia, Vancouver, British Columbia, Canada (J.L.); Department of Cardiology, William Beaumont Hospital, Royal Oaks, MI (G.L.R.); Department of Medicine, Emory University School of Medicine, Atlanta, GA (L.J.S.); and Department of Medicine, Walter Reed Medical Center, Washington, DC (T.C.V.). jkm2001@med.cornell.edu.
Abstract
OBJECTIVE: We sought to examine the risk of mortality associated with nonobstructive coronary artery disease (CAD) and to determine the impact of baseline statin and aspirin use on mortality. APPROACH AND RESULTS: Coronary computed tomographic angiography permits direct visualization of nonobstructive CAD. To date, the prognostic implications of nonobstructive CAD and the potential benefit of directing therapy based on nonobstructive CAD have not been carefully examined. A total of 27 125 consecutive patients who underwent computed tomographic angiography (12 enrolling centers and 6 countries) were prospectively entered into the COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter (CONFIRM) registry. Patients, without history of previous CAD or obstructive CAD, for whom baseline statin and aspirin use was available were analyzed. Each coronary segment was classified as normal or nonobstructive CAD (1%-49% stenosis). Patients were followed up for a median of 27.2 months for all-cause mortality. The study comprised 10 418 patients (5712 normal and 4706 with nonobstructive CAD). In multivariable analyses, patients with nonobstructive CAD had a 6% (95% confidence interval, 1%-12%) higher risk of mortality for each additional segment with nonobstructive plaque (P=0.021). Baseline statin use was associated with a reduced risk of mortality (hazard ratio, 0.44; 95% confidence interval, 0.28-0.68; P=0.0003), a benefit that was present for individuals with nonobstructive CAD (hazard ratio, 0.32; 95% confidence interval, 0.19-0.55; P<0.001) but not for those without plaque (hazard ratio, 0.66; 95% confidence interval, 0.30-1.43; P=0.287). When stratified by National Cholesterol Education Program/Adult Treatment Program III, no mortality benefit was observed in individuals without plaque. Aspirin use was not associated with mortality benefit, irrespective of the status of plaque. CONCLUSIONS: The presence and extent of nonobstructive CAD predicted mortality. Baseline statin therapy was associated with a significant reduction in mortality for individuals with nonobstructive CAD but not for individuals without CAD. CLINICAL TRIAL REGISTRATION: URL: http://clinicaltrials.gov/. Unique identifier NCT01443637.
OBJECTIVE: We sought to examine the risk of mortality associated with nonobstructive coronary artery disease (CAD) and to determine the impact of baseline statin and aspirin use on mortality. APPROACH AND RESULTS: Coronary computed tomographic angiography permits direct visualization of nonobstructive CAD. To date, the prognostic implications of nonobstructive CAD and the potential benefit of directing therapy based on nonobstructive CAD have not been carefully examined. A total of 27 125 consecutive patients who underwent computed tomographic angiography (12 enrolling centers and 6 countries) were prospectively entered into the COronary CT Angiography EvaluatioN For Clinical Outcomes: An InteRnational Multicenter (CONFIRM) registry. Patients, without history of previous CAD or obstructive CAD, for whom baseline statin and aspirin use was available were analyzed. Each coronary segment was classified as normal or nonobstructive CAD (1%-49% stenosis). Patients were followed up for a median of 27.2 months for all-cause mortality. The study comprised 10 418 patients (5712 normal and 4706 with nonobstructive CAD). In multivariable analyses, patients with nonobstructive CAD had a 6% (95% confidence interval, 1%-12%) higher risk of mortality for each additional segment with nonobstructive plaque (P=0.021). Baseline statin use was associated with a reduced risk of mortality (hazard ratio, 0.44; 95% confidence interval, 0.28-0.68; P=0.0003), a benefit that was present for individuals with nonobstructive CAD (hazard ratio, 0.32; 95% confidence interval, 0.19-0.55; P<0.001) but not for those without plaque (hazard ratio, 0.66; 95% confidence interval, 0.30-1.43; P=0.287). When stratified by National Cholesterol Education Program/Adult Treatment Program III, no mortality benefit was observed in individuals without plaque. Aspirin use was not associated with mortality benefit, irrespective of the status of plaque. CONCLUSIONS: The presence and extent of nonobstructive CAD predicted mortality. Baseline statin therapy was associated with a significant reduction in mortality for individuals with nonobstructive CAD but not for individuals without CAD. CLINICAL TRIAL REGISTRATION: URL: http://clinicaltrials.gov/. Unique identifier NCT01443637.
Authors: Jacques Genest; Ruth McPherson; Jiri Frohlich; Todd Anderson; Norm Campbell; André Carpentier; Patrick Couture; Robert Dufour; George Fodor; Gordon A Francis; Steven Grover; Milan Gupta; Robert A Hegele; David C Lau; Lawrence Leiter; Gary F Lewis; Eva Lonn; G B John Mancini; Dominic Ng; Glen J Pearson; Allan Sniderman; James A Stone; Ehud Ur Journal: Can J Cardiol Date: 2009-10 Impact factor: 5.223
Authors: Benjamin J W Chow; George A Wells; Li Chen; Yeung Yam; Paul Galiwango; Arun Abraham; Tej Sheth; Carole Dennie; Rob S Beanlands; Terrence D Ruddy Journal: J Am Coll Cardiol Date: 2010-03-09 Impact factor: 24.094
Authors: Alan D Bell; André Roussin; Raymond Cartier; Wee Shian Chan; James D Douketis; Anil Gupta; Maria E Kraw; Thomas F Lindsay; Michael P Love; Neesh Pannu; Rémi Rabasa-Lhoret; Ashfaq Shuaib; Philip Teal; Pierre Théroux; A Graham Turpie; Robert C Welsh; Jean-François Tanguay Journal: Can J Cardiol Date: 2011 Mar-Apr Impact factor: 5.223
Authors: Benjamin J W Chow; Michael R Freeman; James M Bowen; Leslie Levin; Robert B Hopkins; Yves Provost; Jean-Eric Tarride; Carole Dennie; Eric A Cohen; Dan Marcuzzi; Robert Iwanochko; Alan R Moody; Narinder Paul; John D Parker; Daria J O'Reilly; Feng Xie; Ron Goeree Journal: Arch Intern Med Date: 2011-03-14
Authors: Malek Kass; Christopher A Glover; Marino Labinaz; Derek Y F So; Li Chen; Yeung Yam; Benjamin J W Chow Journal: J Invasive Cardiol Date: 2010-07 Impact factor: 2.022
Authors: Paul M Ridker; Eleanor Danielson; Francisco A H Fonseca; Jacques Genest; Antonio M Gotto; John J P Kastelein; Wolfgang Koenig; Peter Libby; Alberto J Lorenzatti; Jean G MacFadyen; Børge G Nordestgaard; James Shepherd; James T Willerson; Robert J Glynn Journal: N Engl J Med Date: 2008-11-09 Impact factor: 91.245
Authors: Benjamin J W Chow; Arun Abraham; George A Wells; Li Chen; Terrence D Ruddy; Yeung Yam; Nayia Govas; Phoebe Diane Galbraith; Carole Dennie; Rob S Beanlands Journal: Circ Cardiovasc Imaging Date: 2009-01 Impact factor: 7.792
Authors: Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti Journal: Lancet Date: 2009-05-30 Impact factor: 79.321
Authors: Liam R Brunham; Kelsey Lynch; Amy English; Rory Sutherland; Jian Weng; Raymond Cho; Graham C Wong; Aslam H Anis; Gordon A Francis; Nadia A Khan; Bruce McManus; David Wood; Keith R Walley; Jonathon Leipsic; Karin H Humphries; Alison Hoens; Andrew D Krahn; G B John Mancini; Simon Pimstone Journal: Clin Cardiol Date: 2018-06-11 Impact factor: 2.882
Authors: Viviany R Taqueti; Leslee J Shaw; Nancy R Cook; Venkatesh L Murthy; Nishant R Shah; Courtney R Foster; Jon Hainer; Ron Blankstein; Sharmila Dorbala; Marcelo F Di Carli Journal: Circulation Date: 2016-11-14 Impact factor: 29.690